BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18611706)

  • 1. Itraconazole: pharmacology, clinical experience and future development.
    De Beule K
    Int J Antimicrob Agents; 1996 Feb; 6(3):175-81. PubMed ID: 18611706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses.
    Grant SM; Clissold SP
    Drugs; 1989 Mar; 37(3):310-44. PubMed ID: 2540949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Itraconazole. A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infections.
    Haria M; Bryson HM; Goa KL
    Drugs; 1996 Apr; 51(4):585-620. PubMed ID: 8706596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with itraconazole in systemic fungal infections.
    Boogaerts M; Maertens J
    Drugs; 2001; 61 Suppl 1():39-47. PubMed ID: 11219549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
    Van Cutsem J
    Chemotherapy; 1992; 38 Suppl 1():3-11. PubMed ID: 1319313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Itraconazole: a new triazole antifungal agent.
    Zuckerman JM; Tunkel AR
    Infect Control Hosp Epidemiol; 1994 Jun; 15(6):397-410. PubMed ID: 8083506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of oral antifungals and their clinical implications.
    Heykants J; Van Peer A; Lavrijsen K; Meuldermans W; Woestenborghs R; Cauwenbergh G
    Br J Clin Pract Suppl; 1990 Sep; 71():50-6. PubMed ID: 1965419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Itraconazole.
    Piérard GE; Arrese JE; Piérard-Franchimont C
    Expert Opin Pharmacother; 2000 Jan; 1(2):287-304. PubMed ID: 11249550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New antifungal agents in the treatment of superficial dermatomycoses].
    Degreef H
    Ann Dermatol Venereol; 1993; 120(1):21-31. PubMed ID: 8393313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral itraconazole therapy for superficial, subcutaneous, and systemic infections. A panoramic view.
    De Rosso JQ; Gupta AK
    Postgrad Med; 1999 Jul; Spec No():46-52. PubMed ID: 10492666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic optimisation of oral antifungal therapy.
    Schäfer-Korting M
    Clin Pharmacokinet; 1993 Oct; 25(4):329-41. PubMed ID: 8261715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral azole drugs as systemic antifungal therapy.
    Como JA; Dismukes WE
    N Engl J Med; 1994 Jan; 330(4):263-72. PubMed ID: 8272088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral and parenteral treatment with itraconazole in various superficial and systemic experimental fungal infections. Comparisons with other antifungals and combination therapy.
    Van Cutsem J
    Br J Clin Pract Suppl; 1990 Sep; 71():32-40. PubMed ID: 1965417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylaxis of Candida and Aspergillus infections with oral administration of itraconazole.
    Van Cutsem J
    Mycoses; 1994; 37(7-8):243-8. PubMed ID: 7739653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posaconazole: an extended-spectrum triazole antifungal agent.
    Schiller DS; Fung HB
    Clin Ther; 2007 Sep; 29(9):1862-86. PubMed ID: 18035188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylaxis of fungal infections with itraconazole during remission-induction therapy.
    Prentice AG; Bradford GR
    Mycoses; 1989; 32 Suppl 1():96-102. PubMed ID: 2561190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European experience with oral solution and intravenous itraconazole.
    Potter M
    Oncology (Williston Park); 2001 Nov; 15(11 Suppl 9):27-32. PubMed ID: 11757848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal prophylaxis with itraconazole oral solution in neutropenic patients.
    Kibbler CC
    Mycoses; 1999; 42 Suppl 2():121-4. PubMed ID: 10865918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-Candida activity of azoles].
    Van Cutsem J; Van Gerven F; Janssen PA
    Ann Biol Clin (Paris); 1987; 45(6):661-8. PubMed ID: 2830810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluconazole: a new antifungal agent.
    Kowalsky SF; Dixon DM
    Clin Pharm; 1991 Mar; 10(3):179-94. PubMed ID: 2040125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.